(NewsDirect)
Emergent HealthCorp . (OTC: EMGE) , a curator, developer, and marketer ofproducts in the Regenerative Health Space announced today that it hasexecuted a Term Sheet for a firm committed underwriting with anationally recognized investment banking firm for $10,000,000 withrespect to planned corporate financing transactions, including theprivate placement of securities (“pre-IPO Financings”) and theplanned $10 million initial public offering of Emergent subsidiary PharmaZu common stock (“IPO”)that will be applied for listing on NASDAQ or NYSE/AMEX, with NODILUTION to Emergent shareholders. PharmaZu is a pure play, e-commerceproducts and service provider focused on the Pet Community, PetPharmacy and Pet Wellness using Influencers and their content,including pet pharmacy, vet telehealth and pet wellness businesses.Upon the effectiveness of the IPO and listing on a national exchange,PharmaZu plans to acquire a 48-state authorized compounding pharmacylocated in West Palm Beach, FL, doing approximately $10M a year inrevenue, which will serve as the backbone and fulfilment center forPharmaZu, creating a national platform throughout the United States.Subsequently, Emergent plans to distribute to its shareholders, prorata, the shares of PharmaZu as a dividend, when a record date isset.
The raise ofcapital will be used for expanding PharmaZu’s business, productofferings, as well as for acquisitions.
Jim Morrison, former L'Oréal Presidentand Emergents full time CEO stated, “The transaction with Bousteadwill start a new exciting chapter for PharmaZu, while maximizing thevalue to Emergent’s shareholders.”
Adam Books, President of PharmaZu stated,“PharmaZu is poised to start its disrupting of the mail order petbusiness and pet medications, as well as advancing the tele-pet medenvironment. I am very thrilled to be a part of this.”
The execution of theEngagement Letter does not constitute a commitment by Boustead or theCompany to consummate any transaction contemplated hereunder and doesnot ensure the successful placement of securities of any investmentvehicle or the success of Boustead with respect to finding anyinvestors or the success with respect to any transaction. No promises,representations or guarantees have been made.
ABOUT EMERGENTHEALTH CORPORATION
Emergent curates, develops and sells products in theRegenerative Health Space. Its products comprise of ingestibles aswell as topicals for the whole family. The company distributes itsproducts online and through Content Based Shopping using Influencersto position products in their produced content throughout the UnitedStates and Internationally. Its subsidiaries; PharmaZu , is a pure play,e-commerce products and service provider focused on the Pet Community,Pet Pharmacy and Pet Wellness using Influencers and their content,including the pet pharmacy, vet telehealth and pet wellnessbusinesses; Regen BioWellness, is a distributor of various products inthe plant-based and regenerative medical fields. EvolutionaryBiologics , is a new kind of biologics company founded for aclear purpose: bring cutting edge regenerative products to the medicalcommunity. Emergent does not claim any of its products are approved bythe FDA to diagnose, treat, cure or prevent any disease. For moreinformation, please visit Emergent's Website andSocial Media on .
Before using anyproducts, you should always consult with your Veterinarian and/orFamily Doctor.
SAFE HARBOR STATEMENT
This press release contains forward-lookingstatements that can be identified by terminology such as“believes,” “expects,” “potential,” “plans,”“suggests,” “may,” “should,” “could,” “intends,”or similar expressions. Many forward-looking statements involve knownand unknown risks, uncertainties and other factors that may causeactual results to be materially different from any future resultsimplied by such statements. These factors include, but are not limitedto, our ability to continue to enhance our products and systems toaddress industry changes, our ability to expand our customer base andretain existing customers, our ability to effectively compete in ourmarket segment, the lack of public information on our company, ourability to raise sufficient capital to fund our business, operations,our ability to continue as a going concern, and a limited publicmarket for our common stock, among other risks. Many factors aredifficult to predict accurately and are generally beyond thecompany's control. Forward-looking statements speak only as to thedate they are made, and we do not undertake to update forward-lookingstatements to reflect circumstances or events that occur after thedate the forward-looking statements are made.
FOR MORE INFORMATION,PLEASE CONTACT:
Jim Morrison, CEO
Emergent HealthCorporation Website
info@emergenthealthcompany.com
ContactDetails
Emergent Health Corp.
info@emergenthealthcompany.com
CompanyWebsite
https://emergenthealthcompany.com/
Copyright (c) 2023 TheNewswire - All rights reserved.